Determination of nimodipine in the presence of its degradation products and overall kinetics through a stability-indicating lc method

Journal of Chromatographic Science

Volumn 51, Issue 6, 2013, Pages 511-516

  Riekes, Manoela K ^a   Rauber, Gabriela S ^a   Kuminek, Gislaine ^a   Tagliari, Monika P ^a   Cardoso, Simone G ^a   Stulzer, Hellen K ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLORIC ACID; NIMODIPINE; SODIUM HYDROXIDE;

ANALYSIS OF VARIANCE; ARTICLE; CHEMISTRY; DRUG STABILITY; HYDROLYSIS; KINETICS; LIQUID CHROMATOGRAPHY; METHODOLOGY; PHOTOLYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TEMPERATURE;

ANALYSIS OF VARIANCE; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HYDROCHLORIC ACID; HYDROLYSIS; KINETICS; LINEAR MODELS; NIMODIPINE; PHOTOLYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SODIUM HYDROXIDE; TEMPERATURE;

EID: 84878859681     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms174     Document Type: Article

References (23)

1. Nguyen, H.; Bioequivalence reviews: ANDA In Division of bioequivalence review. U.S Food and Drug Administration, (2004).
2. Sweetman, S.C. (ed).; The complete drug reference. Pharmaceutical Press, London, (2009), pp. 1357-1358.
3. Gupta, V.K., Jain, R., Antonijevic, M.M., Khani, H., Siddiqui, M.N., Dwivedi, A., et al.; Assay of nimodipine-an anti hypertensive drug, in bulk form and pharmaceutical formulations by cathodic adsorptive stripping voltametry; International Journal of Eletrochemical Science, (2011); 6: 37-51.
4. Qin, F., Ma, Y., Wang, Y., Chen, L., Wang, D., Li, F.; Determination of nimodipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and pharmacokinetic application; Journal of Pharmaceutical and Biomedical Analysis, (2008); 46: 557-562.
5. Qiu, F., Chen, X., Li, X., Zhong, D.; Determination of nimodipine in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method; Journal of Chromatography B, (2004); 802: 291-297.
6. Krishnaiah, Y.S.R., Bhaskar, P., Jayaram, B., Rama, B., Raju, V., Rao, P.M.M. Development and validation of a reversed-phase HPLC method for the analysis of nimodipine in pharmaceutical dosage forms; Asian Journal of Chemistry, (2003); 15: 1302-1306.
7. Lopez, J.A., Martinez, V., Alonso, R.M., Jimenez, R.M.; High-performance liquid chromatography with amperometric detection applied to the screening of 1,4-dihydropyridines in human plasma; Journal of Chromatography A, (2000); 870: 105-114.
8. Aymard, G., Cayre-Castel, M., Fernandez, C., Lacomblez, L., Diquet, B.; High-performance liquid chromatography with ultraviolet and fluorimetric detection for the simultaneous determination of tacrine, nimodipine, and their respective metabolites in the plasma of patients with Alzheimer disease; Therapeutic Drug Monitoring, (1998); 20: 422-449.
9. Patel, Y.P., Patil, S., Bhoir, I.C., Sundaresan, M.; Isocratic, simultaneous reversed-phase high-performance liquid chromatographic estimation of six drugs for combined hypertension therapy; Journal of Chromatography A, (1998); 828: 283-286.
10. Ragno, G., Veronico, M., Vetuschi, C.; Analysis of nimodipine and its photodegradation product by derivative spectrophotometry and gas chromatography; International Journal of Pharmaceutics, (1995); 119: 115-119.
11. Barmpalexis, P., Kanaze, F.I., Georgarakis, E.; Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology; Journal of Pharmaceutical and Biomedical Analysis, (2009); 49: 1192-1202.
12. Medina, I; Purification of 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate by preparative highperformance liquid chromatography; Analusis, (1999); 27: 447-451.
13. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2 (R1), Geneva, Switzerland, (2005).
14. El-Sayed, M.A.; Stability-indicating high performance liquid chromatographic determination of raubasine in its binary mixture with kinetic study of raubasine acid degradation; Talanta, (2011); 83: 717-723.
15. Vadera, N., Subramanian, G., Musmade, P.; Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form; Journal of Pharmaceutical and Biomedical Analysis, (2007); 43: 722-726.
16. Singh, S., Bakshi, M.; Guidance on conduct of stress tests to determine inherent stability of drugs; Pharmaceutical Technology On-Line, (2000); 23: 1-14.
17. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline: Photostability Testing of New Active Substances and Medicinal Products Q1B, Geneva, Switzerland, (1998).
18. Yoshioka, S., Stella, V.J. Chemical stability of drug substances: Temperature. In Stability of drugs and dosage forms, 1st edition, Chapter
19. Kluwer Academic Publishers, New York, NY, (2002), pp. 61-79.
20. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline: Stability testing of new drug substances and products Q1A (R2), Geneva, Switzerland, (2003).
21. Bakshi, M., Singh, S.; Development of validated stability-indicating assay methods-Critical review; Journal of Pharmaceutical and Biomedical Analysis, (2002); 28: 1011-1040.
22. Swartz, M., Krull, I.; Validation, qualification or verification? LC-GC, (2005); 23: 586-593.
23. Mielcarek, J., Matloka, A.; Comparison of analytical methods for investigating the photostability of 1,4-dihydropyridine derivatives in compliance with recommendations of ICH; International Journal of Pharmaceutical Medicine, (2001); 15: 231-236.